| ABCELLERA BIOLOGICS |
| Kanada |
| Gesundheit |
| CA00288U1066 / A2QKXS |
| 8QQ (Frankfurt) / ABCL (NASDAQ) |
| FRA:8QQ, ETR:8QQ, 8QQ:GR, NASDAQ:ABCL |
| - |
| https://www.abcellera.com.. |
|
AbCellera Biologics Inc. is a clinical-stage biotechnology company that discovers and develops antibody-based medicines targeting unmet medical needs in endocrinology, women's health, immunology, and oncology. It employs an advanced antibody discover..
>Volltext.. |
| 1047.48 Mio. EUR |
| 693.49 Mio. EUR |
| 64.09 Mio. EUR |
| -160.63 Mio. EUR |
| -124.91 Mio. EUR |
| -0.42 EUR |
| 122.18 Mio. EUR |
| 132.25 Mio. EUR |
| -112.25 Mio. EUR |
| 8.71 |
| 129.65% |
| 20.76% |
| - |
| - |
| - |
| - |
| ABCELLERA |
| 25.04.26 |
|